Genesis Study
100+
Okudawunilodiwe
Wonke umuntu
info
Mayelana nalolu hlelo lokusebenza
Isivivinyo se-multicentre sezinyanga eziyi-12 esingahleliwe, esilawulwa kabili, esilawulwayo, esiqhathanisa ushintsho ekusetshenzisweni kukagwayi ngemuva kokushintshela kumandla aphezulu noma aphansi e-nicotine e-cigarettes kubantu ababhemayo abane-Schizophrenia spectrum disorders. Lokhu kuzoba yisilingo se-multicenter, esizoba yizinyanga eziyi-12, sisebenzisa i-randomized, blind-blind, 2-arm parallel, switching design ukuqhathanisa ukusebenza, ukubekezelelana, ukwamukeleka, kanye nephethini yokusetshenziswa phakathi kwe-high (JUUL 5% nicotine) ne-nicotine ephansi amadivayisi wamandla (i-JUUL 1.5% nicotine) kubantu ababhemayo abadala abane-schizophrenia spectrum disorder. Ucwaningo luzokwenzeka kumasayithi we-5: 1 e-UK (London) futhi mhlawumbe ne-4 e-Italy.
Kubuyekezwe ngo-
Ukuphepha kuqala ngokuqonda ukuthi onjiniyela baqoqa futhi babelane kanjani ngedatha yakho. Ubumfihlo bedatha nezinqubo zokuphepha zingahluka kuye ngokusebenzisa kwakho, isifunda, nobudala. Unjiniyela unikeze lolu lwazi futhi angalubuyekeza ngokuhamba kwesikhathi.
Ayikho idatha eyabiwe nezinkampani zangaphandle
Funda kabanzi mayelana nendlela onjiniyela abaveza ngayo ukwabelana
Le app ingaqoqa lezi zinhlobo zedatha
Ulwazi lwe-app nokusebenza
Idatha ibetheliwe lapho ithunyelwa
Ungacela ukuthi leyo datha isulwe
Yini entsha
Performance improvements.
Ukusekelwa kwe-app
Mayelana nonjiniyela
ECLAT SRL
diasmoke@eclatrbc.it
VIA SANTA SOFIA 89
95123 CATANIA
Italy
+44 7886 420447
